NCCN Guidelines® Insights - Palliative Care, Version 2.2021
These NCCN Guidelines Insights summarize the panel’s recent discussions and highlights updates on the importance of fostering adaptive coping strategies for patients and families, and on the role of pharmacologic and nonpharmacologic interventions to optimize symptom management.
Category
  • Palliative Care
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Pharmacy Updates: Best Practices for Transitioning Oncology Therapies from the Inpatient to the Outpatient Setting
It is important for pharmacists to be familiar with the steps that are involved in transitioning oncology therapies that have been historically provided in an inpatient setting to the outpatient setting, and be familiar with the criteria for successful implementation of such an initiative.
Category
  • Best Practices
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date September 17, 2021
NCCN Pharmacy Updates: Infection Concerns with Emerging Immune-targeted Treatments in Immunocompromised Patients with Cancer
Although the toxicity profiles of the newer molecularly targeted drugs are less focused on blood cells than those of traditional cytotoxic therapies, there are still infectious risks; safety and efficacy can only be guaranteed by multidisciplinary teams that have therapeutic expertise in the pharmacology of oral anti-cancer therapy.
Category
  • Supportive Care Topics
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date November 4, 2021
Archived Monthly Oncology Tumor Boards: Systemic Therapy Selection in Metastatic Castration-Resistant Prostate Cancer
The selection of systemic treatments in various lines of therapy for patients with metastatic castration-resistant prostate cancer (CRPC) has become more and more complicated over the last several years. Clinicians who work with patients with metastatic CRPC need to be educated on these updates so that they can help their patients make optimal treatment choices across lines of therapy.
Category
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Monthly Oncology Tumor Boards: Systemic Therapy Selection in Metastatic Castration-Resistant Prostate Cancer
The selection of systemic treatments in various lines of therapy for patients with metastatic castration-resistant prostate cancer (CRPC) has become more and more complicated over the last several years. Clinicians who work with patients with metastatic CRPC need to be educated on these updates so that they can help their patients make optimal treatment choices across lines of therapy.
Category
  • Prostate Cancer
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Event date July 21, 2021
NCCN Pharmacy Updates: Palliative Care for Patients with Cancer - Symptom Management for Pain and Dyspnea
Pharmacists can play a critical role in patient education, therapy recommendations, and therapy management in palliative care and should be familiar with appropriate pharmacologic interventions for symptom management.
Category
  • Palliative Care
Format
  • Live Webinar
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Event date August 27, 2021

Pages